Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy

M Zhang,Jr Zhao,Lq Meng,L Qu,Sq Cai,Xm Li,Sy Liu,Jw Tang,My Shang,Y Wang

doi:10.1111/j.1476-5381.2011.01206.x

M Zhang, Jr Zhao + Show 8 more

Open Access

https://doi.org/10.1111/j.1476-5381.2011.01206.x

Copy DOI

Abstract

BACKGROUND AND PURPOSEThe combination of Chinese herbs, Astragali Radix and Angelicae Sinensis Radix, could alleviate renal interstitial fibrosis. Astragaloside IV (AS-IV) and ferulic acid (FA) are the two major active constituents in this combination. In this study, we employed rats with unilateral ureteral obstruction to determine whether AS-IV and FA have the same renoprotective effects and investigated the mechanisms of this action.EXPERIMENTAL APPROACHRenal pathological changes were evaluated after treatment with AS-IV, FA or AS-IV + FA (AF) for 10 days. Meanwhile, the expression of transforming growth factor β1 (TGF-β1), fibronectin, α-smooth muscle actin (α-SMA), phosphorylation of c-Jun NH2-terminal kinase (p-JNK) and nitric oxide (NO) production in kidney were determined. The expressions of fibronectin, α-SMA, mitogen-activated protein kinases [JNK, extracellular signal-regulated kinases (ERK), P38] in TGF-β1-treated NRK-49F cells or interleukin-1-treated HK-2 cells after AS-IV, FA or AF were assessed.KEY RESULTSAF alleviated the infiltration of mononuclear cells, tubular atrophy and interstitial fibrosis; reduced the expression of fibronectin, α-SMA, TGF-β1 and p-JNK; and dramatically increased the production of NO in obstructed kidneys. Neither AS-IV nor FA alone improved renal damage, but both increased NO production. AF inhibited α-SMA and fibronectin expression in NRK-49F or HK-2 cells. Furthermore, AF significantly inhibited IL-1β-induced JNK phosphorylation, without affecting ERK or P38 phosphorylation. Neither AS-IV nor FA alone had any effect on the cells.CONCLUSIONS AND IMPLICATIONSAS-IV synergizes with FA to alleviate renal tubulointerstitial fibrosis; this was associated with inhibition of tubular epithelial–mesenchymal transdifferentiation (EMT) and fibroblast activation, as well as an increase in NO production in the kidney.

Highlights

Chronic kidney disease (CKD) is widely recognized as a major public health problem that progressively develops to endstage renal disease (ESRD) irrespective of the underlying cause
We identified two major constituents, astragaloside IV (AS-IV) and ferulic acid (FA), from an extract of Astragali Radix and Angelicae Sinensis Radix, which preserve the antifibrotic effects in rats with unilateral ureteral obstruction (UUO)
The results were assessed by one-way analysis of variance (ANOVA) for comparisons among groups

Summary

Introduction

Chronic kidney disease (CKD) is widely recognized as a major public health problem that progressively develops to endstage renal disease (ESRD) irrespective of the underlying cause. A number of pro-inflammatory, profibrotic cytokines, such as transforming growth factor-b1 (TGF-b1) (Schnaper et al, 2009), interleukin-1 (Fan et al, 2001; Vesey et al, 2002) and connective tissue growth factor (Chen et al, 2009), as well as angiotensin II (Gaedeke et al, 2002) are released from the kidney in pathological conditions These factors converge and establish a fibrogenic context that drives the resident cells, including fibroblasts (Qi et al, 2006), pericytes (Lin et al, 2008), tubular cells (Kalluri and Neilson, 2003) and endothelial cells (Zeisberg et al, 2008), to transform into myofibroblasts. The expressions of fibronectin, a-SMA, mitogen-activated protein kinases [JNK, extracellular signal-regulated kinases (ERK), P38] in TGF-b1-treated NRK-49F cells or interleukin-1-treated HK-2 cells after AS-IV, FA or AF were assessed

Methods

Results

Discussion

Conclusion